Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Friday, November 13, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
Authors
Posts by Ogkologos
Ogkologos
4398 POSTS
0 COMMENTS
FDA Approves Alpelisib for PIK3CA-Related Overgrowth Spectrum
Ogkologos
-
April 13, 2022
0
NGS Is Effective in Identifying Actionable Genetic Alterations for Investigational Targeted...
Ogkologos
-
April 13, 2022
0
How Cancer Survivors Can Overcome Common Challenges of Exercise After Treatment
Ogkologos
-
April 12, 2022
0
FDA Approves a Fixed-Dose Combination of Nivolumab and Relatlimab for Unresectable...
Ogkologos
-
April 12, 2022
0
The new home for your research tools
Ogkologos
-
April 11, 2022
0
Increased Efficacy of Pembrolizumab or Pembrolizumab-Chemotherapy with Increasing PD-L1 Expression in...
Ogkologos
-
April 11, 2022
0
The award-winning team transforming breast cancer treatment
Ogkologos
-
April 10, 2022
0
Triple negative breast cancer drug given initial ‘no’ for NHS in...
Ogkologos
-
April 8, 2022
0
Stem cell research: meet the scientist growing ‘mini guts’ in her...
Ogkologos
-
April 8, 2022
0
Treatment with Nivolumab and Low-Dose Ipilimumab is Effective and Tolerable in...
Ogkologos
-
April 8, 2022
0
1
...
206
207
208
...
440
Page 207 of 440
MOST POPULAR
A Vaccine to Treat Non-Hodgkin Lymphoma Advancing in Clinical Trials
May 7, 2019
Aiming to Prevent Cancer Cases, ESMO Calls Against Misleading Alcohol-Labelling Following...
December 3, 2025
Programme Highlights of the ESMO Virtual Congress 2020 [ESMO Media Alert]
August 28, 2020
This Common Antibiotic May Help Support Immune System in Cancer Patients...
December 12, 2019
Load more
HOT NEWS
EMA Recommends Granting a Marketing Authorisation for Nivolumab / Relatlimab
Patient-Reported Outcomes Support the Overall Benefit of Trastuzumab Deruxtecan for Patients...
Belantamab Mafodotin–Containing Triplets Confer a Significant PFS Benefit Among Previously Treated...
Get to Know CaringBridge
Ελληνικά
English (UK)
